Remarkable Response to Erdafitinib in Metastatic Lung Adenocarcinoma With FGFR Fusion

Simple item page
dc.contributor.authorUrrutia Argueta, Samuel A.
dc.contributor.authorHanna, Nasser H.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2021-09-24T21:04:32Z
dc.date.available2021-09-24T21:04:32Z
dc.date.issued2020
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationUrrutia Argueta, S. A., & Hanna, N. H. (2020). Remarkable Response to Erdafitinib in Metastatic Lung Adenocarcinoma With FGFR Fusion. JCO Precision Oncology. https://doi.org/10.1200/PO.20.00110en_US
dc.identifier.urihttps://hdl.handle.net/1805/26650
dc.language.isoenen_US
dc.publisherASCOen_US
dc.relation.isversionof10.1200/PO.20.00110en_US
dc.relation.journalJCO Precision Oncologyen_US
dc.rightsPublisher Policyen_US
dc.sourceAuthoren_US
dc.subjectErdafitiniben_US
dc.subjectfibroblast growth factor receptor (FGFR) signalingen_US
dc.subjectcase reporten_US
dc.titleRemarkable Response to Erdafitinib in Metastatic Lung Adenocarcinoma With FGFR Fusionen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
UrrutiaArgueta2020Remarkable-AAM.pdf
Size:
113.35 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works